RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction Chemotherapy

被引:12
作者
Ball, Brian J. [1 ]
Hsu, Meier [2 ]
Devlin, Sean M. [3 ]
Famulare, Christopher [4 ]
Cai, Sheng F. [1 ]
Dunbar, Andrew [1 ]
Epstein-Peterson, Zachary D. [5 ]
Menghrajani, Kamal [1 ]
Glass, Jacob L. [1 ]
Taylor, Justin [1 ]
Viny, Aaron D. [1 ]
Goldberg, Aaron D. [1 ]
Tallman, Martin S. [6 ]
Stein, Eytan M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
D O I
10.1182/blood-2019-125319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
18
引用
收藏
页数:4
相关论文
empty
未找到相关数据